Orthofix International | OFIX - Interest Expense On Debt


Orthofix International reported 4.68M in Interest Expense on Debt for its fiscal quarter ending in September of 2025.





Interest Expense On Debt Change Date
Accuray USD 2.88M 72K Dec/2024
AngioDynamics USD 102K 2K Sep/2025
Artivion USD 5.53M 589K Dec/2025
AtriCure USD 1.21M 159K Mar/2026
Dexcom USD 3.1M 1.1M Mar/2026
EDAP TMS EUR 1.46M 1.42M Mar/2026
Globus Medical USD 5.49B 48.7M Jun/2026
Inogen 1.03M 384K Mar/2025
Insulet USD 11M 3.7M Jun/2026
Integra LifeSciences USD 22.99M 529K Jun/2026
J&J USD 43M 25M Mar/2026
Medtronic USD 176M 5M Mar/2026
Mesa Laboratories USD 3.02M 180K Sep/2024
Orthofix International 4.68M 731K Sep/2025
Plus Therapeutics USD 62K 25K Dec/2023
Smith & Nephew USD 69M 1000K Dec/2025
STAAR Surgical USD 800K 799K Sep/2025
Stryker USD 47.93B 1.64B Jun/2026
Tandem Diabetes Care USD 1.15B 808K Jun/2026
Teleflex USD 27.95M 2.24M Jun/2026
Veracyte USD 2K 1000 Dec/2023
Zimmer Biomet Holdings USD 22.8B 22.73B Jun/2026